| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-03 | FY 2024
FILED 2024-12-28 | FY 2023
FILED 2023-12-30 |
|---|---|---|---|
| Revenue (Total Sales) | $8.60B | $9.09B | $9.21B |
| YoY Revenue Growth % | -5.4% | -1.2% | — |
| Gross Profit | $3.73B | $3.41B | — |
| Gross Margin % | 43.4% | 37.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$43.0M | -$713.0M | $39.0M |
| Operating Margin % | -0.5% | -7.8% | 0.4% |
| Net Income (GAAP) | $44.0M | -$336.0M | $30.0M |
| EBITDA (Normalized) | $158.6M | -$568.2M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$46.0M | $85.0M | $287.0M |
| Capital Expenditures (CapEx) | $252.0M | $181.0M | — |
| Free Cash Flow (FCF) | -$298.0M | -$96.0M | $287.0M |
| FCF Margin % | -3.5% | -1.1% | 3.1% |
| Return on Invested Capital (ROIC %) | -1.4% | -27.0% | — |
| Cash & Short-Term Equivalents | $3.12B | $1.87B | — |
| Total Debt (Short + Long Term) | $3.41B | $1.79B | — |
| Total Stockholders' Equity | $2.20B | $2.17B | — |